Dr Awada has published more than 27 book chapters, and more than 45 peer-review papers in international journals. His research focusses on new active anticancer drugs for solid tumours (new cytotoxics and molecular targeted therapies), and to individualize the treatments according to the tumour characteristics.
Dr Awada is a member of several EORTC groups including EORTC Head & Neck Cancer Cooperative Group. He is a member of the ESMO Educational Steering Committee for Developmental therapeutics.
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!